DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,623 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $8,826,039 | -10.0% | 37,580 | -4.3% | 1.15% | -2.4% |
Q1 2024 | $9,808,003 | +22.8% | 39,276 | +15.5% | 1.18% | +7.4% |
Q4 2023 | $7,985,240 | -6.4% | 34,000 | -1.1% | 1.09% | -9.1% |
Q3 2023 | $8,529,926 | +4.2% | 34,381 | +0.8% | 1.20% | +8.6% |
Q2 2023 | $8,185,920 | -1.4% | 34,108 | +3.6% | 1.11% | -4.5% |
Q1 2023 | $8,298,669 | -1.8% | 32,926 | +3.4% | 1.16% | -9.2% |
Q4 2022 | $8,454,423 | +3.8% | 31,853 | +1.0% | 1.28% | -2.2% |
Q3 2022 | $8,147,000 | +2.0% | 31,543 | +0.1% | 1.31% | +5.1% |
Q2 2022 | $7,985,000 | -17.0% | 31,496 | -4.0% | 1.24% | -3.9% |
Q1 2022 | $9,625,000 | -12.3% | 32,814 | -1.7% | 1.29% | -24.7% |
Q4 2021 | $10,981,000 | +7.0% | 33,377 | -0.9% | 1.72% | -2.4% |
Q3 2021 | $10,258,000 | +13.9% | 33,695 | +0.4% | 1.76% | +12.4% |
Q2 2021 | $9,003,000 | +17.6% | 33,548 | -1.4% | 1.56% | +14.4% |
Q1 2021 | $7,658,000 | +2.6% | 34,022 | +1.3% | 1.37% | -3.9% |
Q4 2020 | $7,462,000 | +3.8% | 33,591 | +0.6% | 1.42% | -8.2% |
Q3 2020 | $7,192,000 | +23.7% | 33,398 | +1.6% | 1.55% | +14.7% |
Q2 2020 | $5,812,000 | +30.3% | 32,865 | +2.0% | 1.35% | +9.4% |
Q1 2020 | $4,459,000 | -5.9% | 32,216 | +4.4% | 1.24% | +22.2% |
Q4 2019 | $4,737,000 | +9.2% | 30,861 | +2.7% | 1.01% | +0.6% |
Q3 2019 | $4,339,000 | +4.9% | 30,040 | +3.8% | 1.00% | +4.9% |
Q2 2019 | $4,135,000 | +25.6% | 28,932 | +16.0% | 0.96% | +20.1% |
Q1 2019 | $3,293,000 | +17.2% | 24,946 | -8.4% | 0.80% | +23.3% |
Q4 2018 | $2,809,000 | +69.2% | 27,236 | +78.3% | 0.65% | +68.1% |
Q3 2018 | $1,660,000 | +661.5% | 15,275 | +269.7% | 0.38% | +613.0% |
Q2 2018 | $218,000 | -84.8% | 4,132 | -71.8% | 0.05% | -85.0% |
Q1 2018 | $1,434,000 | +14.2% | 14,645 | +8.2% | 0.36% | +16.5% |
Q4 2017 | $1,256,000 | +64.8% | 13,530 | +52.3% | 0.31% | +57.4% |
Q3 2017 | $762,000 | +9.3% | 8,881 | +7.6% | 0.20% | +2.6% |
Q2 2017 | $697,000 | +22.9% | 8,255 | +24.4% | 0.19% | +21.5% |
Q1 2017 | $567,000 | – | 6,635 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |